L. Jochheim

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

A. Vogel, J. Marquardt, A. Saborowski, 2022, Therapeutic advances in medical oncology.

Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

E. D. De Toni, D. Bettinger, V. Keitel, 2022, Cancers.

Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study

J. Mayerle, E. D. De Toni, A. Geier, 2022, Journal of Cancer Research and Clinical Oncology.